Doping Prevalence among U.S. Elite Athletes Subject to Drug Testing under the World Anti-Doping Code.

Davoren AK, Rulison K, Milroy J, Grist P, Fedoruk M, Lewis L, Wyrick D

DOI: 10.1186/s40798-024-00721-9
Published: 2024 May 20
Container: Sports medicine - open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40798-024-00721-9,
  title = {Doping Prevalence among U.S. Elite Athletes Subject to Drug Testing under the World Anti-Doping Code.},
  author = {Davoren AK and Rulison K and Milroy J and Grist P and Fedoruk M and Lewis L and Wyrick D},
  year = {2024},
  journal = {Sports medicine - open},
  doi = {10.1186/s40798-024-00721-9},
  url = {https://doi.org/10.1186/s40798-024-00721-9}
}

RIS

TY  - JOUR
TI  - Doping Prevalence among U.S. Elite Athletes Subject to Drug Testing under the World Anti-Doping Code.
AU  - Davoren AK
AU  - Rulison K
AU  - Milroy J
AU  - Grist P
AU  - Fedoruk M
AU  - Lewis L
AU  - Wyrick D
PY  - 2024
JO  - Sports medicine - open
DO  - 10.1186/s40798-024-00721-9
UR  - https://doi.org/10.1186/s40798-024-00721-9
ER  -

APA

AK, D., K, R., J, M., P, G., M, F., L, L., & D, W. (2024). Doping Prevalence among U.S. Elite Athletes Subject to Drug Testing under the World Anti-Doping Code.. Sports medicine - open. https://doi.org/10.1186/s40798-024-00721-9

Source records

pubmed · retrieved 2026-11-10T11:51:33.857Z